Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2021 / Articles / Aug / Human Proteins: Now Free with No Ads
Discovery & Development Digital Technologies Technology and Equipment Drug Discovery Technology & Manufacturing Drug Discovery Research News

Human Proteins: Now Free with No Ads

Google’s DeepMind has opened an enormous protein structure database up to citizens of the Internet

By Angus Stewart 08/21/2021 1 min read Quick Read (pre 2022)

Share

Google’s AI subsidiary, DeepMind, has taken another great leap forward in science, business, and open sourcing by releasing both their AlphaFold algorithm source code and their protein structure database.

AlphaFold is a program created by DeepMind in 2016 to predict protein structures. Four years after its launch, AlphaFold’s predictions matched those of lab techniques. The program has consistently outperformed all its peers – and, over time, itself. It works at rapid speed, and with need of far less resources than any human in a lab.

Both AlphaFold’s v2.0 algorithm and its library of 350,000 protein sequences are now available online for free. DeepMind’s CEO, Demis Hassabis, has expressed his hopes that the pharmaceutical industry will make use of this valuable new resource.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Angus Stewart

Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.

More Articles by Angus Stewart

False

Advertisement

Recommended

False

Related Content

The Next Decade of Cell and Gene Therapies
Advanced Medicine Bioprocessing - Upstream & Downstream Trends & Forecasts Digital Technologies
The Next Decade of Cell and Gene Therapies

May 7, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Partnership Cuts Cost of CAR T Manufacturing
Advanced Medicine Technology and Equipment Digital Technologies
Partnership Cuts Cost of CAR T Manufacturing

March 13, 2025

4 min read

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that? Trenchant and Autolomous explore the possibilities.

Forecasting Medicine Use and Controlling Supply Chains
Digital Technologies Standards & Regulation Supply Chain
Forecasting Medicine Use and Controlling Supply Chains

March 19, 2025

3 min read

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

AI, Big Data, and Digital Disruption
Digital Technologies Clinical Trials
AI, Big Data, and Digital Disruption

March 31, 2025

7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.